Augmentation of ADAMTS9 gene expression by IL-1β is reversed by NFκB and MAPK inhibitors, but not PI3 kinase inhibitors

Cell Biochemistry and Function

Volumn 31, Issue 7, 2013, Pages 539-544

  Uysal, Sema ^a   Ünal, Zahide Nur ^b   Erdoǧan, Serpil ^a   Akyol, Sümeyya ^b   Ramazan Yigitoglu M ^b   Hirohata, Satoshi ^c   Işik, Bünyamin ^b   Demircan, Kadir ^b,c  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

ADAMTS9; Aggrecan; BAY117085; Curcumin; Inhibitors; MAPK; NF B; PI3 kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS 9; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA ACTIN; COMPLEMENTARY DNA; CURCUMIN; I KAPPA B; INTERLEUKIN 1BETA; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RNA; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CHONDROSARCOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CONTROL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION;

ADAMTS9; AGGRECAN; BAY117085; CURCUMIN; INHIBITORS; MAPK; NFΚB; PI3 KINASE;

ADAM PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; TUMOR CELLS, CULTURED;

EID: 84884981385     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2932     Document Type: Article

References (28)

1. van den Berg WB. Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthritis Cartilage 2011; 19: 338-341.
2. Tortorella MD, Burn TC, Pratta MA, et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999; 284: 1664-1666.
3. Apte SS. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 2004; 36: 981-985.
4. Rodel F, Hantschel M, Hildebrandt G, et al. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappa B) in EA.hy.926 endothelial cells after low-dose X-irradiation. Int J Radiat Biol 2004; 80: 115-123.
5. Ghosh S, May MJ, Kopp EB. NF-kappa B and rel proteins: evolutionarily conserved mediators of immune responses. Ann Rev Immunol 1998; 16: 225-260.
6. Broom OJ, Widjaya B, Troelsen J, et al. Mitogen activated protein kinases: a role in inflammatory bowel disease? Clin Exp Immunol 2009; 158: 272-280.
7. Clark AR, Dean JL. The p38 MAPK pathway in rheumatoid arthritis: a sideways look. Open Rheumatol J 2012; 6: 209-219.
8. Saccani S, Pantano S, Natoli G. p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 2002; 3: 69-75.
9. Beier F, Loeser RF. Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes. J Cell Biochem 2010; 110: 573-580.
10. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genetics 2006; 7: 606-619.
11. Banham-Hall E, Clatworthy MR, Okkenhaug K. The therapeutic potential for PI3K inhibitors in autoimmune rheumatic diseases. Open Rheumatol J 2012; 6: 245-258.
12. Li B, Yang Y, Jiang S, et al. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway. Int J Oncol 2012; 41: 1809-1819.
13. Rommel C, Camps M, Ji H. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 2007; 7: 191-201.
14. Bian Q, Wang YJ, Liu SF, et al. Osteoarthritis: genetic factors, animal models, mechanisms, and therapies. Front Biosci (Elite Ed) 2012; 4: 74-100.
15. Demircan K, Hirohata S, Nishida K, et al. ADAMTS-9 is synergistically induced by interleukin-1 beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 2005; 52: 1451-1460.
16. Granet C, Maslinski W, Miossec P. Increased AP-1 and NF-kappa B activation and recruitment with the combination of the proinflammatory cytokines IL-1 beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. Arthritis Res Ther 2004; 6: R190-R198.
17. Granet C, Miossec P. Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappa B in osteoblast-like cells. Cytokine 2004; 26: 169-177.
18. Liacini A, Sylvester J, Li WQ, et al. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002; 21: 251-262.
19. Barnes PJ, Larin M. Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
20. Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 2011; 112: 3507-3514.
21. Kuno K, Bannai K, Hakozaki M, et al. The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential. Biochem Biophys Res Commun 2004; 319: 1327-1333.
22. Tetsunaga T, Nishida K, Furumatsu T, et al. Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells. Osteoarthritis Cartilage 2011; 19: 222-232.
23. Pei Y, Harvey A, Yu XP, et al. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Osteoarthritis Cartilage 2006; 14: 749-758.
24. Liacini A, Sylvester J, Li WQ, et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 2003; 288: 208-217.
25. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973; 25: 447-452.
26. Shakibaei M, Schulze-Tanzil G, John T, et al. Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: an immunomorphological study. Ann Anat 2005; 187: 487-497.
27. Henrotin Y, Clutterbuck AL, Allaway D, et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage 2010; 18: 141-149.
28. Meini S, Cucchi P, Catalani C, et al. Bradykinin and B(2) receptor antagonism in rat and human articular chondrocytes. Br J Pharmacol 2011; 162: 611-622.